Clinical Trials Browser

Phase 2 × Lymphoma × Bevacizumab × Clear all

NCT00217425 2023-06-18

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

Phase 2 Completed

46 enrolled 7 charts

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01327612 2021-02-21

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Phase 2 Completed

12 enrolled 21 charts

EndocrineGastrointestinalLymphoidSarcomaThoracic

Carcinoid Tumor, Carcinoma, Non-Small-Cell Lung, Lymphoma, Neoplasm Metastasis, Sarcoma, Colorectal Neoplasms

NCT00816595 2017-06-15

Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2 Completed

68 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00193492 2015-01-05

A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma

Phase 2 Completed

60 enrolled 7 charts

Lymphoma, Lymphoma, Follicular

NCT00081861 2012-04-05

Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma

Phase 2 Completed

13 enrolled 5 charts

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell